More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$56.23B
EPS
12.61
P/E ratio
58.6
Price to sales
13.93
Dividend yield
--
Beta
1.667982
Previous close
$707.50
Today's open
$710.46
Day's range
$697.26 - $715.19
52 week range
$356.14 - $769.98
show more
CEO
Jonathan J. Mazelsky
Employees
11000
Headquarters
Westbrook, ME
Exchange
Nasdaq Global Select
Shares outstanding
79851330
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge?
IDXX surges 75.6% YTD as strong CAG Diagnostics momentum and high-demand software solutions fuel growth.
Zacks Investment Research • Dec 4, 2025

Idexx (IDXX) Up 1.5% Since Last Earnings Report: Can It Continue?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Dec 3, 2025

What Makes Idexx Laboratories (IDXX) a Strong Momentum Stock: Buy Now?
Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zacks Investment Research • Nov 28, 2025

Idexx (IDXX) Upgraded to Buy: Here's What You Should Know
Idexx (IDXX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks Investment Research • Nov 28, 2025

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?
IDEXX Laboratories' (IDXX) recent jump has investors questioning whether it's still the best bet—or if a stronger opportunity exists elsewhere. A closer look at its key competitor suggests there may be a clearer winner.
Forbes • Nov 24, 2025

3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks Investment Research • Nov 21, 2025

Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average
From a technical perspective, Idexx Laboratories (IDXX) is looking like an interesting pick, as it just reached a key level of support. IDXX recently overtook the 20-day moving average, and this suggests a short-term bullish trend.
Zacks Investment Research • Nov 20, 2025

Pet Healthcare Spending Is Soaring. These Stocks Are Positioned to Clean Up
The steep increase in pet healthcare costs have doubled over the past five years, according to NPR.
24/7 Wall Street • Nov 14, 2025

Baron Asset Fund Q3 2025 Performance Review
Baron Asset Fund underperformed for a second consecutive quarter as U.S. equities continued their strong rally from the market lows reached on April 8. From a sector perspective, stock selection in IT and Communication Services was responsible for about three-quarters of the underperformance in the period. Stock selection in Consumer Discretionary, Financials, and Industrials hampered relative results.
Seeking Alpha • Nov 13, 2025

November Is The Best Month — And 5 Stocks Are Already On Fire
No single month beats November for S&P 500 stock market performance. And a handful of stocks are already taking off.
Investors Business Daily • Nov 6, 2025

¹ Disclosures

Open an M1 investment account to buy and sell IDEXX Laboratories Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.